ClinicalTrials.gg
Drug

Indacaterol clinical trials

Also written QAB149 and Onbrez.

Includes 15 studies of Indacaterol maleate, 5 studies of Indacaterol acetate and 1 study of Indacaterol fumarate.

studies test it
86
open now
1
in phase 3
33
first study started
2004

How each study uses indacaterol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the indacaterol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
1 Jul 2011 · ARCAPTA NEOHALER · NDA 022383 (FDA, Drugs@FDA; as indacaterol maleate)
European Union
29 Nov 2009 · Onbrez Breezhaler · EMEA/H/C/001114 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Indacaterol
34
Indacaterol 150 μg
7
Indacaterol 300 μg
5
Indacaterol 150 µg
4
Onbrize
3

Brand

Onbrez
2

Development codes

QAB149
5

In one entry with another drug

Given together, or one or the other

indacaterol/glycopyrrolate
3
Indacaterol/glycopyrronium
2

Studies by the year they started

86 studies that test it; most in 2008 (12)

Studies that test indacaterol, by start year
YearStudies
20042
20068
200710
200812
200910
20106
20115
20125
20138
20144
20154
20164
20174
20211
20221
20231
20241

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
27
Phase 3
33
Phase 4
22
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 71 · Other 15

Novartis Pharmaceuticals (43) · Novartis (25) · University of Milan (3) · National Institute of Respiratory Diseases, Mexico (2) · Orion Corporation, Orion Pharma (2) · University of Michigan (1) · Centre Hospitalier Universitaire de Besancon (1) · Centro Cardiologico Monzino (1)

Often tested with

Tested in the same studies.

Glycopyrrolate (11) · Tiotropium (7) · Mometasone Furoate (3) · Salmeterol Xinafoate (2) · Fluticasone (2) · Budesonide (2) · Vilanterol (2) · Formoterol (1)

Studies

Open first, then newest update. How each study uses indacaterol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 86

See all 86 studies that test indacaterol →

Given beside what is tested · 2 — indacaterol is usual care or a partner of the new treatment
As the comparator · 8 — what is tested is compared with indacaterol

Codes

What other systems call indacaterol · ClinicalTrials.gg INT004916

  • MeSH (NLM) C510790indacaterolConfirmed NLM, Wikidata
  • UNII (FDA) 8OR09251MQINDACATEROLConfirmed FDA, NLM, Wikidata
  • RxNorm 1114326Confirmed FDA, Wikidata
  • Wikidata Q425654indacaterolConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C81644IndacaterolOne source FDA
  • DrugBank DB05039One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.